Zobrazeno 1 - 1
of 1
pro vyhledávání: '"59"'
Autor:
Tarek Sahmoud, Yutaka Tokuda, Yoshiaki Rai, Hirotaka Iwase, Shozo Ohsumi, Hirofumi Mukai, Ashok Panneerselvam, Woo Chul Noh, Yoshinori Ito, Puttisak Puttawibul, Hideo Inaji, Tetiana Taran, Vichien Srimuninnimit, Hiroji Iwata, Norikazu Masuda, Takahiro Nakayama, Mona El-Hashimy, Shinzaburo Noguchi, Jun Horiguchi, Shinji Ohno, Katsumasa Kuroi, Byeong Woo Park
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background The addition of mTOR inhibitor everolimus (EVE) to exemestane (EXE) was evaluated in an international, phase 3 study (BOLERO-2) in patients with hormone-receptor-positive (HR+) breast cancer refractory to letrozole or anastrozole. The safe